Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $7.59 million. The enterprise value is -$1.30 million.

Market Cap	7.59M
Enterprise Value	-1.30M

Important Dates

The last earnings date was Friday, November 8, 2024, after market close.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

MBRX has 2.84 million shares outstanding. The number of shares has increased by 37.97% in one year.

Current Share Class	2.84M
Shares Outstanding	2.84M
Shares Change (YoY)	+37.97%
Shares Change (QoQ)	+46.04%
Owned by Insiders (%)	3.28%
Owned by Institutions (%)	6.00%
Float	2.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.07
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.08, with a Debt / Equity ratio of 0.07.

Current Ratio	2.08
Quick Ratio	1.68
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -141.49% and return on invested capital (ROIC) is -82.70%.

Return on Equity (ROE)	-141.49%
Return on Assets (ROA)	-57.45%
Return on Capital (ROIC)	-82.70%
Revenue Per Employee	n/a
Profits Per Employee	-$1.68M
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.83% in the last 52 weeks. The beta is 1.86, so MBRX's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-69.83%
50-Day Moving Average	2.53
200-Day Moving Average	4.28
Relative Strength Index (RSI)	52.87
Average Volume (20 Days)	60,127

Short Selling Information

The latest short interest is 122,380, so 4.30% of the outstanding shares have been sold short.

Short Interest	122,380
Short Previous Month	171,524
Short % of Shares Out	4.30%
Short % of Float	4.99%
Short Ratio (days to cover)	5.63

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.92M
Pretax Income	-26.82M
Net Income	-30.15M
EBITDA	-28.79M
EBIT	-28.92M
Earnings Per Share (EPS)	-$11.22

Full Income Statement

Balance Sheet

The company has $9.41 million in cash and $506,000 in debt, giving a net cash position of $8.90 million or $3.13 per share.

Cash & Cash Equivalents	9.41M
Total Debt	506,000
Net Cash	8.90M
Net Cash Per Share	$3.13
Equity (Book Value)	7.48M
Book Value Per Share	2.49
Working Capital	6.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$24.19 million and capital expenditures -$94,000, giving a free cash flow of -$24.28 million.

Operating Cash Flow	-24.19M
Capital Expenditures	-94,000
Free Cash Flow	-24.28M
FCF Per Share	-$8.54

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.97%
Shareholder Yield	-37.97%
Earnings Yield	-396.98%
FCF Yield	-319.69%

Analyst Forecast

The average price target for MBRX is $31.00, which is 1,061.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.00
Price Target Difference	1,061.05%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Mar 22, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1